Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26804
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDalli, Lachlan L-
dc.contributor.authorAndrew, Nadine E-
dc.contributor.authorCadilhac, Dominique A-
dc.contributor.authorKim, Joosup-
dc.contributor.authorSanfilippo, Frank M-
dc.contributor.authorKilkenny, Monique F-
dc.date2021-06-24-
dc.date.accessioned2021-06-28T06:12:05Z-
dc.date.available2021-06-28T06:12:05Z-
dc.date.issued2021-08-11-
dc.identifier.citationThe International Journal of Pharmacy Practice 2021; 29(4): 397-399en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26804-
dc.description.abstractTo assess the agreement between pharmaceutical claims data and patient-reported medication use after stroke. Claims data from the Pharmaceutical Benefits Scheme were used to estimate medication use for a subset of participants registered in the Australian Stroke Clinical Registry in 2016. Estimates on medication use were validated against patient-reported responses (considered the reference standard). For antihypertensive and lipid-lowering medications, the sensitivity of claims data was excellent (85-87%) and the specificity was good (73-78%). Whereas for antithrombotic medications, sensitivity was modest (61%), but specificity was excellent (85%). Pharmaceutical claims data can be used to infer medication use after stroke with mostly good to excellent sensitivity and specificity compared with the patient report.en
dc.language.isoeng-
dc.subjectadministrative claimsen
dc.subjecthealthcare validation studyen
dc.subjectpharmacoepidemiologyen
dc.subjectregistriesen
dc.subjectStrokeen
dc.titleAgreement between pharmaceutical claims data and patient-reported medication use after stroke.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe International Journal of Pharmacy Practiceen
dc.identifier.affiliationStroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australiaen
dc.identifier.affiliationPeninsula Clinical School, Central Clinical School, Monash University, Frankston, VIC, Australiaen
dc.identifier.affiliationSchool of Population and Global Health, The University of Western Australia, Perth, WA, Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen
dc.identifier.doi10.1093/ijpp/riab032en
dc.type.contentTexten
dc.identifier.orcid0000-0003-1449-9132en
dc.identifier.orcid0000-0002-4846-2840en
dc.identifier.orcid0000-0001-8162-682Xen
dc.identifier.orcid0000-0002-4079-0428en
dc.identifier.orcid0000-0003-3639-0787en
dc.identifier.orcid0000-0002-3375-287Xen
dc.identifier.pubmedid34165141-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

2
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.